How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

44,202 results for

Metabolic Syndrome

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Effect of omega-3 fatty acid supplementation on components of metabolic syndrome in patients with Human Immunodeficiency Virus infection (HIV) in High Activity Antiretroviral Therapy (HAART): a systematic review and meta-analysis of randomized controlled

Effect of omega-3 fatty acid supplementation on components of metabolic syndrome in patients with Human Immunodeficiency Virus infection (HIV) in High Activity Antiretroviral Therapy (HAART): a systematic review and meta-analysis of randomized controlled Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

142. Does a gluten-free diet improve metabolic syndrome? A systematic review

Does a gluten-free diet improve metabolic syndrome? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

143. Impact of fecal microbiota transplantation on obesity with metabolic syndrome - a systematic review and meta-analysis

Impact of fecal microbiota transplantation on obesity with metabolic syndrome - a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

144. Effects of probiotics on metabolic syndrome: a systematic review of randomized clinical trials

Effects of probiotics on metabolic syndrome: a systematic review of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

145. Prevalence of metabolic syndrome in people living with HIV on antiretroviral therapy: a systematic review and meta-analysis

Prevalence of metabolic syndrome in people living with HIV on antiretroviral therapy: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

146. A systematic review and meta-analysis of the association between circulating gut microbiota- derived Trimethylamiine N-Oxide (TMAO) and components of metabolic syndrome

A systematic review and meta-analysis of the association between circulating gut microbiota- derived Trimethylamiine N-Oxide (TMAO) and components of metabolic syndrome Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

147. Impact of treatment of periodontal on the metabolic syndrome: a systematic review

Impact of treatment of periodontal on the metabolic syndrome: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

148. Prevalence of metabolic syndrome and factors associated with it among adult population in India: a systematic review and meta-analysis

Prevalence of metabolic syndrome and factors associated with it among adult population in India: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

149. Do dietary choices alone alter the risk of developing metabolic syndrome?

Do dietary choices alone alter the risk of developing metabolic syndrome? Do dietary choices alone alter the risk of developing metabolic syndrome? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics Do dietary choices alone alter the risk of developing metabolic syndrome? View/ Open Date 2013-09 Format Metadata Abstract (...) In studies of patient populations controlled for differences in dietary content alone, independent of weight loss or exercise changes, diets with high glycemic index foods, low whole grain and fiber content, and low fruit and vegetable content are associated with an increased incidence of metabolic syndrome (strength of recommendation [SOR]: B, multiple large cohort studies). In the short term, however, switching patients at high risk for metabolic syndrome from a high- to low-glycemic index diet doesn't

2014 Clinical Inquiries

150. Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan (PubMed)

Evaluation of the Japanese Metabolic Syndrome Risk Score (JAMRISC): a newly developed questionnaire used as a screening tool for diagnosing metabolic syndrome and insulin resistance in Japan To prevent the onset of lifestyle-related diseases associated with metabolic syndrome (MetS) in Japan, research into the development of a useful screening method is strongly desired. We developed a new screening questionnaire (JAMRISC) utilizing a logistic regression model and evaluated its ability (...) to predict the development of MetS, type 2 diabetes and other lifestyle-related diseases in Japanese populace.JAMRISC questionnaire was sent to 1,850 individuals in Rumoi, a small city in Hokkaido. We received a total of 1,054 valid responses. To maximize the target individuals accurately diagnosed with MetS, logistic regression analysis was used to generate a unique metabolic syndrome score calculation formula as taking into consideration the clinical relevance of each question item as individual

Full Text available with Trip Pro

2016 Environmental health and preventive medicine

151. Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome (PubMed)

Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome 27013318 2016 07 04 2018 11 13 1471-2318 16 2016 Mar 24 BMC geriatrics BMC Geriatr Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. 71 10.1186/s12877-016-0241-2 Lee Sangjin S Office for Planning and Coordination, Division of Planning and Coordination, Ministry of Health & Welfare, 13, Doum

Full Text available with Trip Pro

2016 BMC geriatrics

152. Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record (PubMed)

Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record Metabolic syndrome is a common underdiagnosed condition among psychiatric patients exacerbated by second-generation antipsychotics, with the exception of aripiprazole and ziprasidone. This study evaluated the prescribing and treating behavior with regard to antipsychotics and metabolic syndrome of psychiatrists before and after (...) implementation of a mandatory admission order set and electronic notification of results.Baseline data from 9,100 consecutive psychiatric admissions to a mental health hospital (July 2013-July 2014) were compared to postintervention data (July 2014-January 2015), which included 1,499 consecutive patient records. The intervention initiated standardized admission testing with electronic notification to psychiatrists when patients met metabolic syndrome criteria (according to Axis III of the DSM-IV). Charts

Full Text available with Trip Pro

2016 The Primary Care Companion for CNS Disorders

153. Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. (PubMed)

Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. Gender is thought to be an important factor in metabolic syndrome and its outcomes. Despite a number of studies that have demonstrated differences in metabolism and its components that are dependent on gender, limited information about gender differences on the characteristics of metabolic syndrome and its components is available regarding the Korean old adult population (...) . This study aimed to identify gender differences in characteristics of the metabolic syndrome and other risk factors for cardiovascular disease.Secondary analysis of data from a nationwide cross-sectional survey for health examination at the time of transitioning from midlife to old age was performed. Multiple logistic regression models were used to estimate adjusted odds ratios and 95% confidence intervals for gender differences among the Korean 66-year-old population with metabolic syndrome.Gender

Full Text available with Trip Pro

2016 BMC Geriatrics

154. Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome (PubMed)

Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome A growing body of evidence suggests that metabolic syndrome is associated with endocrine disorders including thyroid dysfunction. Thyroid dysfunction in metabolic syndrome patients may further add to cardiovascular disease risk thereby increasing mortality. This study was done to assess thyroid function in metabolic syndrome patients and evaluate its relationship with the components (...) of metabolic syndrome.A cross sectional study was carried out among 169 metabolic syndrome patients at B P Koirala Institute of Health Sciences, Dharan, Nepal. Anthropometric measurements (height, weight, waist circumference) and blood pressure were taken. Fasting blood samples were analysed to measure glucose, triglyceride, high density lipoprotein (HDL) cholesterol and thyroid hormones (triiodothyronine, thyroxine and thyroid stimulating hormone).Thyroid dysfunction was seen in 31.9 % (n = 54) metabolic

Full Text available with Trip Pro

2016 Clinical Diabetes and Endocrinology

155. The Effect of Different Metabolic Syndrome: Definitions on the Relationship Between Metabolic Syndrome and LUTS in Men With Benign Prostatic Enlargement (PubMed)

The Effect of Different Metabolic Syndrome: Definitions on the Relationship Between Metabolic Syndrome and LUTS in Men With Benign Prostatic Enlargement Because various criteria are used to define metabolic syndrome (MetS), this study examines the most relevant definition for patients with benign prostatic enlargement (BPE). Most studies regarding the link between MetS and BPE/lower urinary tract symptoms (LUTS) have used the National Cholesterol Education Program Adult Treatment Panel III

Full Text available with Trip Pro

2016 American journal of men's health

156. Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA₂ in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome. (PubMed)

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA₂ in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome. Apolipoprotein (Apo) B-48 is an intestinally derived lipoprotein that is expected to be a marker for cardiovascular disease (CVD). Lipoprotein-associated phospholipase A₂ (Lp-PLA₂) is a vascular-specific inflammatory marker and important risk predictor of CVD (...) . The aim of this study was to explore the effect of pitavastatin treatment and life style modification (LSM) on ApoB-48 and Lp-PLA₂ levels in metabolic syndrome (MS) patients at relatively low risk for CVD, as a sub-analysis of a previous multi-center prospective study.We enrolled 75 patients with MS from the PROPIT study and randomized them into two treatment groups: 2 mg pitavastatin daily+intensive LSM or intensive LSM only. We measured the change of lipid profiles, ApoB-48 and Lp-PLA₂ for 48

Full Text available with Trip Pro

2016 Endocrinology and metabolism (Seoul, Korea) Controlled trial quality: uncertain

157. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. (PubMed)

Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Human studies have shown the beneficial effects of probiotic microorganisms on the parameters of metabolic syndrome (MetS) and other cardiovascular risks, but to our knowledge the effect of Bifidobacterium lactis has not yet been reported. The aim of this study was to evaluate the effect of consumption of milk (...) containing the probiotic B. lactis HN019 on the classical parameters of MetS and other related cardiovascular risk factors.Fifty-one patients with MetS were selected and divided into a control group (n = 25) and a probiotic group (n = 26). The probiotic group consumed fermented milk with probiotics over the course of 45 d. The effects of B. lactis on lipid profile, glucose metabolism, and proinflammatory cytokines (tumor necrosis factor-α and interleukin-6) were assessed in blood samples

2016 Nutrition (Burbank, Los Angeles County, Calif.) Controlled trial quality: uncertain

158. Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: The atherosclerosis risk in communities study. (PubMed)

Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: The atherosclerosis risk in communities study. Some obese adults are not afflicted by the metabolic abnormalities often associated with obesity (the 'metabolically healthy obese' (MHO)); however, they may be at increased risk of developing cardiometabolic abnormalities in the future. Little is known about the relative incidence of individual components of metabolic syndrome (MetSyn).We used (...) data from a multicenter, community-based cohort aged 45-64 years at recruitment (the Atherosclerosis Risk In Communities study) to examine the first appearance of any MetSyn component, excluding waist circumference. Body mass index (BMI, kg m-2) and cardiometabolic data were collected at four triennial visits. Our analysis included 3969 adults who were not underweight and free of the components of MetSyn at the initial visit. Participants were classified as metabolically healthy normal weight (MHNW

Full Text available with Trip Pro

2017 International Journal of Obesity

159. Effects of Sex Hormone Treatment on the Metabolic Syndrome in Transgender Individuals: Focus on Metabolic Cytokines. (PubMed)

Effects of Sex Hormone Treatment on the Metabolic Syndrome in Transgender Individuals: Focus on Metabolic Cytokines. Hormonal treatment in transgender persons affects many components of the metabolic syndrome (MS).To determine the role of direct hormonal effects, changes in metabolic cytokines, and body composition on metabolic outcomes.24 transwomen and 45 transmen from the European Network for the Investigation of Gender Incongruence were investigated at baseline and after 12 months (...) with chemerin, resistin, and FGF-21 and were inversely related to changes in the waist/hip ratio and leptin and adipocyte fatty acid-binding protein levels.The effects of hormonal therapy on different components of the MS are sex-specific and involve a complex interplay of direct hormonal effects, changes in body composition, and metabolic cytokine secretion.Copyright © 2017 Endocrine Society

2017 Journal of Clinical Endocrinology and Metabolism

160. Gene expression analysis identify a metabolic and cell function alterations as a hallmark of obesity without metabolic syndrome in peripheral blood, a pilot study. (PubMed)

Gene expression analysis identify a metabolic and cell function alterations as a hallmark of obesity without metabolic syndrome in peripheral blood, a pilot study. Understanding molecular basis involved in overweight is an important first step in developing therapeutic pathways against excess in body weight gain.The purpose of our pilot study was to evaluate the gene expression profiles in the peripheral blood of obese patients without other metabolic complications.A sample of 17 obese patients (...) without metabolic syndrome and 15 non obese control subjects was evaluated in a prospective way. Following 'One-Color Microarray-Based Gene Expression Analysis' protocol Version 5.7 (Agilent p/n 4140-90040), cRNA was hybridized with Whole Human Genome Oligo Microarray Kit (Agilent p/n G2519F-014850) containing 41,000+ unique human genes and transcripts.The average age of the study group was 43.6 ± 19.7 years with a sex distribution of 64.7% females and 35.3% males. No statistical differences were

2017 Clinical nutrition (Edinburgh, Scotland)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>